Company profile
Allied Corp.
OTC: ALID · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Kelowna, BCCIK 0001575295Reports USD
#1044 of 1,418 Healthcare companies by revenue73rd-percentile growth
EA Score
——FH —DQ 22GM —SS 41
v0.1 · 25/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, operating margin
Methodology →Revenue TTM
$72.1k
Rev growth YoY (TTM)
-53.9%
Net income (FY)
-$4.0M
Employees
150
as of 2026-08-28
Market cap
$57.7k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$96.2k$96.2k2024
Net income-$4.0M-$4.0M2024
Operating income-$4.0M-$4.0M2024
Total assets$2.1M$2.1M2024
Liabilities$9.7M$9.7M2024
Equity-$7.5M-$7.5M2024
Revenue trend
FY2020 – FY2024 · USD
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Allied Corp.’s revenue?
Allied Corp. booked $96.2k in FY2024 revenue, growing 33% year over year — faster than most Healthcare companies we track, at a -4134.1% net margin.
Peers · Healthcare
Meridian Holdings, Inc.——Profusa, Inc. Common Stock9DTherapeutic Solutions International, Inc.——Actinium Pharmaceuticals, Inc.28DCitius Pharmaceuticals, Inc.42DAIM ImmunoTech Inc.36DKey facts
CEOMichael Moses
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersKelowna, BC
ExchangeOTC: ALID
Employees150
IPO date2019-08-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.